Loading…
Attending this event?
Monday, June 17 • 8:00am - 10:00am
#100: Opening Plenary and Keynote Address

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Component Type: Forum

Join our opening plenary session, Innovation: The Possibilities, The Boundaries: Charting New Horizons, led by Tom and Emily Whitehead, who will give the incredible journey of Emily Whitehead, the pioneering pediatric patient who defied the odds and became the first in the world to undergo CAR T-cell therapy. Tom and Emily will share their invaluable insights into the transformative power of CAR-T therapy, offering a unique perspective that promises to captivate and inspire. Dean Kamen will discuss the Future of Regenerative Therapies, How Public-Private Partnerships Can Impact Advancement. Following your keynotes, we will have a panel discussion. Attendees can expect a lively and engaging discussion, with a diverse range of perspectives and insights from panelists who are leaders and at the forefront of our industry; including panelists from the Gates Foundation, regulatory agencies, and the patient perspective.

Chair

Marwan Fathallah, MBA, MSc

Speaker

Developing Cell Therapies for Cancer Patients
Carsten Linnermann, PhD

Keynote Speaker: Insights into the Transformative Power of CAR-T Therapy
Tom Whitehead

Keynote Speaker: Insights into the Transformative Power of CAR-T Therapy
Emily Whitehead

Keynote Speaker: Future of Regenerative Therapies - How Public-Private Partnerships Can Impact Advancement
Dean Kamen

Plenary Panel: Innovation - The Possibilities, the Boundaries - Charting New Horizons
David Mukanga, PhD, MPH

Panelist: Innovation
Dean Kamen

Panelist: EMA Perspective
Emer Cooke, MBA, MSc

Panelist: FDA Perspective
Peter W. Marks, MD, PhD

Panelist: Patient Perspective
Stacy Hurt, MBA, MHA


Speakers
avatar for Marwan Fathallah

Marwan Fathallah

President & Global Chief Executive, DIA, United States
Prior to joining DIA in 2023, Fathallah was the Operating Officer and EVP at Ortho Clinical Diagnostics, accountable for Operations, Post Market Product Science and Engineering, Regulatory, Quality, Medical, Clinical, Scientific Affairs, and Process Excellence. Before joining Ortho... Read More →
avatar for Dean Kamen

Dean Kamen

Founder, DEKA Research & Development Corp., United States
Serial inventor and the founder of the ARMI-Advance Regeneratve Manufacturing Institute
avatar for Peter Marks

Peter Marks

Director, Center for Biologics Evaluation and Research, FDA, United States
Peter Marks received his graduate degree in cell and molecular biology and his medical degree at New York University and completed Internal Medicine residency and Hematology/Medical Oncology training at Brigham and Women’s Hospital in Boston. He has worked in academic settings teaching... Read More →
avatar for Emily Whitehead

Emily Whitehead

Co-founder, Emily Whitehead Foundation, United States
Emily Whitehead was diagnosed with acute lymphoblastic leukemia (ALL) in May 2010 when she was five years old. Typically, children diagnosed with this type of leukemia have an 85% to 90% chance of being cured; however, she relapsed twice. The leukemia became resistant to treatment... Read More →
avatar for Tom Whitehead

Tom Whitehead

Co-founder and President, Emily Whitehead Foundation, United States
Emily’s parents, Tom and Kari, were not willing to give up. They heard about an experimental treatment, called CAR T-cell therapy, that was available as a Phase I clinical trial at Children’s Hospital of Philadelphia (CHOP). In April 2012, they enrolled Emily in the clinical trial... Read More →
avatar for Stacy Hurt, MBA, MHA

Stacy Hurt, MBA, MHA

Chief Patient Officer, Parexel International, United States
Stacy Hurt, MHA, MBA is an award-winning 25 year pharma executive who bridges the industry/consumer gap as a stage IV cancer survivor and 24/7 caregiver to her son with a rare disease. Her unique professional and personal experience position her as an esteemed patient advocate as... Read More →
avatar for Emer Cooke

Emer Cooke

Executive Director, Chair, ICMRA, The European Medicines Agency, Netherlands
Ms Cooke is Executive Director of the EMA and Chair of ICMRA. Starting her mandate as ED in June 2020 amid a public health crisis of unprecedented scale she announced “My number one priority will be to drive forward EMA’s response to the pandemic and the work already ongoing to... Read More →
avatar for Carsten Linnermann

Carsten Linnermann

Chief Executive Officer, Neogene Therapeutics, AstraZeneca Group, Netherlands
Co-founder and CEO of Neogene Therapeutics, AstraZeneca Group will speak about his experience in developing cell therapies for cancer patients and the importance of collaboration to transform innovative science into new medicines for patients.

Monday June 17, 2024 8:00am - 10:00am PDT
Ballroom San Diego Convention Center 111 W Harbor Drive, San Diego, CA 92101 USA
  00: Plenary, Forum |   09: Regulatory, Forum |   06: TranslationalDelivery Tech-PrecMedicine, Forum